Efficacy and safety analysis of hypofractionated and conventional fractionated radiotherapy in postoperative breast cancer patients

被引：0
|
作者：
Yongkai Lu
Beina Hui
Di Yang
Yi Li
Binglin Li
Luping Zhou
Lei Xu
Fengwen Tang
Wei Wang
Ruijuan Chen
Dongli Zhao
机构：
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Radiation Oncology
[2] Shaanxi Provincial Tumor Hospital,Department of Radiation Oncology
[3] Affiliated Hospital of Xi’an Jiaotong University Health Science Center,Department of Obstetrics and Gynecology
[4] Xi’an Central Hospital,Department of Radiation Oncology
[5] the Affiliated Hospital of Xi’an Jiaotong University,undefined
[6] Xijing Hospital,undefined
[7] Air Force Medical University,undefined
来源：
BMC Cancer | / 24卷
关键词：
Breast cancer; Hypofractionated radiotherapy; Conventional fractionated radiotherapy; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effectiveness of hypofractionated and normofractionated radiotherapy in a triple-negative breast cancer model
    Grosche, Sinja
    Bogdanova, Natalia, V
    Ramachandran, Dhanya
    Luedeking, Marcus
    Stemwedel, Katharina
    Christiansen, Hans
    Henkenberens, Christoph
    Merten, Roland
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer
    Dreyfuss, Alexandra D.
    Barsky, Andrew R.
    Taunk, Neil K.
    Clark, Amy S.
    Freedman, Gary M.
    BREAST JOURNAL, 2019, 25 (06) : 1097 - 1103
  • [23] Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
    Choi, Hoon Sik
    Jang, Hong Seok
    Kang, Ki Mun
    Choi, Byung-ock
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [24] Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
    Hoon Sik Choi
    Hong Seok Jang
    Ki Mun Kang
    Byung-ock Choi
    Radiation Oncology, 14
  • [25] Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy
    Sindhu, M.
    Malik, Monica
    Ahmed, Syed F.
    Valiyaveettil, Deepthi
    INDIAN JOURNAL OF CANCER, 2020, 57 (04) : 423 - 427
  • [26] An observational study comparing the dosimetry and clinical effects of conventional versus hypofractionated radiotherapy in elderly patients of early breast cancer
    Chhatui, Bappaditya
    Roy, Niladri
    Chakrabarty, Shinjini
    Choudhury, Alakananda
    Ravy, Aishwarya
    Mazumder, Justice
    Majhi, Dharma
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2025, 21 (01) : 118 - 123
  • [27] Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis
    Dong, Jinling
    Yang, Ya
    Han, Dan
    Zhao, Qian
    Liu, Chengxin
    Sun, Hongfu
    Wang, Zhongtang
    Lin, Haiqun
    Huang, Wei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [28] Efficacy and safety of compound Kushen injection combined with chemotherapy on postoperative Patients with breast cancer A meta-analysis of randomized controlled trials
    Ao, Man
    Xiao, Xu
    Li, Qingshan
    MEDICINE, 2019, 98 (03)
  • [29] Evaluation of local control and tolerance of hypofractionated radiotherapy for the treatment of breast cancer: analysis by the propensity score
    Kone, A. S.
    Ahid, S.
    James, L.
    Diabate, K.
    Diakite, A.
    Mouhajir, N.
    Dossou, R.
    Abouqal, R.
    Cherrah, Y.
    Benjaafar, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 76 - 76
  • [30] Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity
    Palumbo, Isabella
    Mariucci, Cristina
    Falcinelli, Lorenzo
    Perrucci, Elisabetta
    Lancellotta, Valentina
    Podlesko, Anna Maria
    Marcantonini, Marta
    Saldi, Simonetta
    Bini, Vittorio
    Aristei, Cynthia
    BREAST CANCER, 2019, 26 (03) : 290 - 304
12345